{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:43:04Z","timestamp":1794807784457,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Nano technology possesses a role in the enhancement of anti-inflammatory and anti-Alzheimer activities of the synthesized triazole\/thiadiazole hybrids\n                    <jats:bold>3a\u2013c<\/jats:bold>\n                    . Selective propargylation of 5-amino-1,3,4-thiadiazole-2-thiol with propargyl bromide and triethyl amine followed by Click reaction with different azides to afford 1,2,3-triazole\/thiadiazole hybrids\n                    <jats:bold>3a\u2013c<\/jats:bold>\n                    . The structure of the synthesized compounds was confirmed using different spectroscopic analysis such as FT-IR,\n                    <jats:sup>1<\/jats:sup>\n                    H NMR,\n                    <jats:sup>13<\/jats:sup>\n                    C NMR and elemental analysis. Moreover, the synthesized compounds were prepared in nano scale via chitosan to enhance their solubility and compatibility, and their size was evaluated via transmission electron microscope (TEM). The formulated nanoparticles are found to be relatively stable with higher positive zeta potential 22.5\u201329.5 mV and particle size 29\u201380 nm. The studied compounds were further subjected to molecular docking in the active site of four particular proteins AChE, BuChE, LOX-5 and COX-2.The synthesized compounds and their nanoformulations were tested as anti-inflammatory and anti-Alzheimer as acetylcholinesterase inhibitors. The result revealed that nanoformulations\n                    <jats:bold>N-(3a\u2013c)<\/jats:bold>\n                    exhibited superior inhibitory activity compared to their synthesized counterparts\n                    <jats:bold>3a\u2013c<\/jats:bold>\n                    , demonstrating enhanced potency against AChE, BuChE, NO formation, iNOS, LOX-5, and RBC lysis.\n                    <jats:bold>N-3a<\/jats:bold>\n                    showed the strongest iNOS inhibition, while\n                    <jats:bold>N-3b<\/jats:bold>\n                    was the most effective BuChE inhibitor. Notably, all nanoformulations matched the reference drug in LOX-5 inhibition and outperformed diclofenac K in protecting against RBC lysis. These results highlight the potential of these hybrids as anti-inflammatory and anti-Alzheimer agents.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-26140-8","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:25:26Z","timestamp":1763702726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Design and synthesis of 1,2,3-triazole thiadiazole hybrids with in vitro and in silico evaluation of their anti-inflammatory and anti-alzheimer activities"],"prefix":"10.1038","volume":"15","author":[{"given":"Ahmed R.","family":"Rabee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamida","family":"Abdel-Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saied M.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Sobhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa Ahmad","family":"Ghareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aalaa K.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"7","key":"26140_CR1","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1021\/cr200409f","volume":"113","author":"P Thirumurugan","year":"2013","unstructured":"Thirumurugan, P., Matosiuk, D. & Jozwiak, K. Click chemistry for drug development and diverse chemical\u2013biology applications. Chem. Rev. 113(7), 4905\u20134979 (2013).","journal-title":"Chem. Rev."},{"issue":"2","key":"26140_CR2","first-page":"120","volume":"14","author":"B Amna","year":"2021","unstructured":"Amna, B. & Ozturk, T. Click chemistry: A fascinating method of connecting organic groups. Org. Commun. 14(2), 120 (2021).","journal-title":"Org. Commun."},{"issue":"10","key":"26140_CR3","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1021\/acs.jmedchem.4c00652","volume":"67","author":"Q Guan","year":"2024","unstructured":"Guan, Q. et al. Triazoles in medicinal chemistry: Physicochemical properties, bioisosterism, and application. J. Med. Chem. 67(10), 7788\u20137824 (2024).","journal-title":"J. Med. Chem."},{"issue":"5","key":"26140_CR4","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1039\/D2RA05592A","volume":"13","author":"G Singh","year":"2023","unstructured":"Singh, G. et al. CuAAC ensembled 1, 2, 3-triazole linked nanogels for targeted drug delivery: A review. RSC Adv. 13(5), 2912\u20132936 (2023).","journal-title":"RSC Adv."},{"key":"26140_CR5","doi-asserted-by":"publisher","first-page":"104827","DOI":"10.1016\/j.reactfunctpolym.2021.104827","volume":"160","author":"K Hiba","year":"2021","unstructured":"Hiba, K. & Sreekumar, K. Multi-arm dendronized polymer as a unimolecular micelle: Synthesis, characterization and application as organocatalyst in the synthesis of N-unsubstituted 1, 2, 3-triazoles. React. Funct. Polym. 160, 104827 (2021).","journal-title":"React. Funct. Polym."},{"issue":"16","key":"26140_CR6","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1002\/ejoc.201301695","volume":"2014","author":"A Lauria","year":"2014","unstructured":"Lauria, A. et al. 1, 2, 3-Triazole in heterocyclic compounds, endowed with biological activity, through 1, 3-dipolar cycloadditions. Eur. J. Org. Chem. 2014(16), 3289\u20133306 (2014).","journal-title":"Eur. J. Org. Chem."},{"key":"26140_CR7","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s11164-020-04318-1","volume":"47","author":"N Poonia","year":"2021","unstructured":"Poonia, N., Lal, K. & Kumar, A. Design, synthesis, antimicrobial evaluation and in silico studies of symmetrical bis (urea-1, 2, 3-triazole) hybrids. Res. Chem. Intermed. 47, 1087\u20131103 (2021).","journal-title":"Res. Chem. Intermed."},{"issue":"3","key":"26140_CR8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.aac.2023.11.003","volume":"3","author":"Y Jiang","year":"2024","unstructured":"Jiang, Y. et al. Novel quinoxalinone-1, 2, 3-triazole derivatives as potential antifungal agents for plant anthrax disease: design, synthesis, antifungal activity and SAR study. Adv. Agrochem. 3(3), 222\u2013228 (2024).","journal-title":"Adv. Agrochem."},{"issue":"9","key":"26140_CR9","doi-asserted-by":"publisher","first-page":"24643","DOI":"10.1021\/acsomega.4c01075","volume":"29","author":"MS Ayoup","year":"2024","unstructured":"Ayoup, M. S. et al. Design and synthesis of quinoxaline hybrids as modulators of HIF-1a, VEGF, and p21 for halting colorectal cancer. ACS Omega 29(9), 24643\u201324653 (2024).","journal-title":"ACS Omega"},{"key":"26140_CR10","doi-asserted-by":"publisher","first-page":"130076","DOI":"10.1016\/j.bmcl.2024.130076","volume":"117","author":"X Hou","year":"2025","unstructured":"Hou, X. et al. Synthesis of dolutegravir derivatives modified by 1, 2, 3-triazole structure and their anti-inflammatory activity in LPS-induced BV2 cells. Bioorg. Med. Chem. Lett. 117, 130076 (2025).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"26140_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.4155\/fmc-2020-0301","volume":"13","author":"Z Tan","year":"2021","unstructured":"Tan, Z. et al. Triazole-containing hybrids with anti-mycobacterium tuberculosis potential\u2013Part I: 1, 2, 3-triazole. Future Med. Chem. 13(7), 643\u2013662 (2021).","journal-title":"Future Med. Chem."},{"issue":"1","key":"26140_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-025-01449-7","volume":"19","author":"Y-F Lv","year":"2025","unstructured":"Lv, Y.-F. et al. Synthesis and anti-inflammatory activity of novel 1, 2, 3-triazole-derivatives from 7-oxodehydroabietic acid. BMC Chem. 19(1), 1\u201311 (2025).","journal-title":"BMC Chem."},{"key":"26140_CR13","doi-asserted-by":"publisher","first-page":"1468561","DOI":"10.3389\/fmed.2024.1468561","volume":"11","author":"Q Xiang","year":"2024","unstructured":"Xiang, Q. et al. Revealing the potential therapeutic mechanism of Lonicerae Japonicae Flos in Alzheimer\u2019s disease: A computational biology approach. Front. Med. 11, 1468561 (2024).","journal-title":"Front. Med."},{"issue":"2","key":"26140_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/ph16020179","volume":"16","author":"SA Khan","year":"2023","unstructured":"Khan, S. A. et al. An overview of 1, 2, 3-triazole-containing hybrids and their potential anticholinesterase activities. Pharmaceuticals 16(2), 179 (2023).","journal-title":"Pharmaceuticals"},{"issue":"8","key":"26140_CR15","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/ddr.21726","volume":"81","author":"QQ Lu","year":"2020","unstructured":"Lu, Q. Q. et al. Nitrogen-containing flavonoid and their analogs with diverse B-ring in acetylcholinesterase and butyrylcholinesterase inhibition. Drug Dev. Res. 81(8), 1037\u20131047 (2020).","journal-title":"Drug Dev. Res."},{"issue":"4","key":"26140_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/13543776.2017.1272575","volume":"27","author":"KM Dawood","year":"2017","unstructured":"Dawood, K. M. & Farghaly, T. A. Thiadiazole inhibitors: A patent review. Expert Opin. Ther. Pat. 27(4), 477\u2013505 (2017).","journal-title":"Expert Opin. Ther. Pat."},{"issue":"46","key":"26140_CR17","doi-asserted-by":"publisher","first-page":"44287","DOI":"10.1021\/acsomega.3c07003","volume":"8","author":"S Bathula","year":"2023","unstructured":"Bathula, S. et al. 2-Amino thiazole derivatives as prospective aurora kinase inhibitors against breast cancer: QSAR, ADMET prediction, molecular docking, and molecular dynamic simulation studies. ACS Omega 8(46), 44287\u201344311 (2023).","journal-title":"ACS Omega"},{"key":"26140_CR18","doi-asserted-by":"crossref","unstructured":"Serban, G., et al., 2-Amino-1, 3, 4-thiadiazole as a potential scaffold for promising antimicrobial agents. Drug Des. Dev. Ther. 1545\u20131566 (2018).","DOI":"10.2147\/DDDT.S155958"},{"key":"26140_CR19","doi-asserted-by":"publisher","first-page":"138438","DOI":"10.1016\/j.molstruc.2024.138438","volume":"1312","author":"S Ahmad","year":"2018","unstructured":"Ahmad, S. et al. A review on recent progress in synthesis and biological activities of thiadiazole and its derivatives. J. Mol. Struct. 1312, 138438 (2018).","journal-title":"J. Mol. Struct."},{"issue":"9","key":"26140_CR20","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1080\/10406638.2019.1709085","volume":"41","author":"HK Mahmoud","year":"2021","unstructured":"Mahmoud, H. K., Abbas, A. A. & Gomha, S. M. Synthesis, antimicrobial evaluation and molecular docking of new functionalized bis (1, 3, 4-thiadiazole) and bis (thiazole) derivatives. Polycycl. Aromat. Compd. 41(9), 2029\u20132041 (2021).","journal-title":"Polycycl. Aromat. Compd."},{"key":"26140_CR21","doi-asserted-by":"publisher","first-page":"127470","DOI":"10.1016\/j.molstruc.2019.127470","volume":"1203","author":"H Mu\u011flu","year":"2020","unstructured":"Mu\u011flu, H., Yakan, H. & Shouaib, H. A. New 1, 3, 4-thiadiazoles based on thiophene-2-carboxylic acid: Synthesis, characterization, and antimicrobial activities. J. Mol. Struct. 1203, 127470 (2020).","journal-title":"J. Mol. Struct."},{"issue":"1","key":"26140_CR22","doi-asserted-by":"publisher","first-page":"e70035","DOI":"10.1002\/ddr.70035","volume":"86","author":"MI Serag","year":"2025","unstructured":"Serag, M. I. et al. Design, synthesis, biological evaluation and molecular docking study of new 1, 3, 4-thiadiazole-based compounds as EGFR inhibitors. Drug Dev. Res. 86(1), e70035 (2025).","journal-title":"Drug Dev. Res."},{"issue":"2\u20133","key":"26140_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1515\/znb-2023-0078","volume":"79","author":"A Israr","year":"2024","unstructured":"Israr, A., Hameed, S. & Al-Masoudi, N. A. Synthesis, anti-HIV and cytotoxicity evaluation of chiral 2, 5-disubstituted 1, 3, 4-thiadiazole derivatives bearing the sulfonamide scaffold. Zeitschrift f\u00fcr Naturforschung B 79(2\u20133), 89\u201397 (2024).","journal-title":"Zeitschrift f\u00fcr Naturforschung B"},{"issue":"9","key":"26140_CR24","doi-asserted-by":"publisher","first-page":"7808","DOI":"10.1080\/10406638.2022.2140172","volume":"43","author":"HA Katouah","year":"2023","unstructured":"Katouah, H. A. Synthesis, antioxidant, and cytotoxic activities of new 1, 3, 4-thiadiazoldiazenylacrylonitrile derivatives. Polycycl. Aromat. Compd. 43(9), 7808\u20137827 (2023).","journal-title":"Polycycl. Aromat. Compd."},{"key":"26140_CR25","doi-asserted-by":"publisher","first-page":"110027","DOI":"10.1016\/j.intimp.2023.110027","volume":"118","author":"M Hatami","year":"2023","unstructured":"Hatami, M. et al. Thiadiazole\u2013A promising structure in design and development of anti-Alzheimer agents. Int. Immunopharmacol. 118, 110027 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"26140_CR26","doi-asserted-by":"crossref","unstructured":"Podila, N., et al., Design, synthesis, biological and computational screening of novel pyridine-based thiadiazole derivatives as prospective anti-inflammatory agents. Heliyon 10(8) (2024).","DOI":"10.1016\/j.heliyon.2024.e29390"},{"issue":"3","key":"26140_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/17425255.2024.2328152","volume":"20","author":"CT Supuran","year":"2024","unstructured":"Supuran, C. T. Drug interactions of carbonic anhydrase inhibitors and activators. Expert Opin. Drug Metab. Toxicol. 20(3), 143\u2013155 (2024).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"1","key":"26140_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40824-019-0166-x","volume":"23","author":"D Chenthamara","year":"2019","unstructured":"Chenthamara, D. et al. Therapeutic efficacy of nanoparticles and routes of administration. Biomater. Res. 23(1), 20 (2019).","journal-title":"Biomater. Res."},{"issue":"23","key":"26140_CR29","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.3390\/molecules24234209","volume":"24","author":"EB Souto","year":"2019","unstructured":"Souto, E. B. et al. Nanoparticle delivery systems in the treatment of diabetes complications. Molecules 24(23), 4209 (2019).","journal-title":"Molecules"},{"issue":"17","key":"26140_CR30","doi-asserted-by":"publisher","first-page":"11476","DOI":"10.1021\/acs.chemrev.7b00194","volume":"117","author":"C Kinnear","year":"2017","unstructured":"Kinnear, C. et al. Form follows function: Nanoparticle shape and its implications for nanomedicine. Chem. Rev. 117(17), 11476\u201311521 (2017).","journal-title":"Chem. Rev."},{"issue":"4","key":"26140_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4062\/biomolther.2020.204","volume":"29","author":"V Natesan","year":"2021","unstructured":"Natesan, V. & Kim, S.-J. Diabetic nephropathy\u2013a review of risk factors, progression, mechanism, and dietary management. Biomol. Ther. 29(4), 365 (2021).","journal-title":"Biomol. Ther."},{"key":"26140_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-12-813586-0.00004-3","volume":"28","author":"M Nasrollahzadeh","year":"2019","unstructured":"Nasrollahzadeh, M. et al. Applications of nanotechnology in daily life. Interface Sci. Technol. 28, 113\u2013143 (2019).","journal-title":"Interface Sci. Technol."},{"issue":"20","key":"26140_CR33","doi-asserted-by":"publisher","first-page":"20226","DOI":"10.1021\/acsomega.4c10965","volume":"10","author":"EM Hassan","year":"2025","unstructured":"Hassan, E. M. et al. Nanoformulations for hydrazones; synthesis, characterization, parasitology, and histopathology investigations. ACS Omega 10(20), 20226\u201320235 (2025).","journal-title":"ACS Omega"},{"issue":"1","key":"26140_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10048-025-00821-y","volume":"26","author":"K Abbas","year":"2025","unstructured":"Abbas, K. et al. Multi-target approach to Alzheimer\u2019s disease prevention and treatment: Antioxidant, anti-inflammatory, and amyloid-modulating mechanisms. Neurogenetics 26(1), 1\u201320 (2025).","journal-title":"Neurogenetics"},{"issue":"22","key":"26140_CR35","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.3390\/molecules29225314","volume":"29","author":"VT Angelova","year":"2024","unstructured":"Angelova, V. T., Stoyanov, B. P. & Simeonova, R. New insights into the development of donepezil-based hybrid and natural molecules as multi-target drug agents for Alzheimer\u2019s disease treatment. Molecules 29(22), 5314 (2024).","journal-title":"Molecules"},{"key":"26140_CR36","doi-asserted-by":"publisher","first-page":"132712","DOI":"10.1016\/j.molstruc.2022.132712","volume":"1259","author":"B Bakchi","year":"2022","unstructured":"Bakchi, B. et al. An overview on applications of SwissADME web tool in the design and development of anticancer, antitubercular and antimicrobial agents: A medicinal chemist\u2019s perspective. J. Mol. Struct. 1259, 132712 (2022).","journal-title":"J. Mol. Struct."},{"issue":"12","key":"26140_CR37","doi-asserted-by":"publisher","first-page":"104217","DOI":"10.1016\/j.drudis.2024.104217","volume":"29","author":"W Bagrowska","year":"2024","unstructured":"Bagrowska, W., Karasewicz, A. & G\u00f3ra, A. Comprehensive analysis of acetylcholinesterase inhibitor and reactivator complexes: implications for drug design and antidote development. Drug Discov. Today 29(12), 104217 (2024).","journal-title":"Drug Discov. Today"},{"issue":"23","key":"26140_CR38","doi-asserted-by":"publisher","first-page":"17083","DOI":"10.1016\/S0021-9258(19)85305-X","volume":"268","author":"A Ordentlich","year":"1993","unstructured":"Ordentlich, A. et al. Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. J. Biol. Chem. 268(23), 17083\u201317095 (1993).","journal-title":"J. Biol. Chem."},{"issue":"22","key":"26140_CR39","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1016\/j.bmcl.2016.10.041","volume":"26","author":"\u00dcD \u00d6zkay","year":"2016","unstructured":"\u00d6zkay, \u00dc. D. et al. Design, synthesis, and AChE inhibitory activity of new benzothiazole\u2013piperazines. Bioorg. Med. Chem. Lett. 26(22), 5387\u20135394 (2016).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"26140_CR40","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/jcb.30483","volume":"124","author":"RA Concei\u00e7\u00e3o","year":"2023","unstructured":"Concei\u00e7\u00e3o, R. A. et al. Structure-based design of new N-benzyl-piperidine derivatives as multitarget-directed AChE\/BuChE inhibitors for Alzheimer\u2019s disease. J. Cell. Biochem. 124(11), 1734\u20131748 (2023).","journal-title":"J. Cell. Biochem."},{"key":"26140_CR41","doi-asserted-by":"publisher","first-page":"5204","DOI":"10.1007\/s00044-014-1091-0","volume":"23","author":"G Rajitha","year":"2014","unstructured":"Rajitha, G. et al. Synthesis, biological evaluation, and molecular docking studies of N-(\u03b1-acetamido cinnamoyl) aryl hydrazone derivatives as antiinflammatory and analgesic agents. Med. Chem. Res. 23, 5204\u20135214 (2014).","journal-title":"Med. Chem. Res."},{"key":"26140_CR42","unstructured":"Dennington, R., T.A. Keith, and J.M. Millam, GaussView, version 6.0. 16. Semichem Inc Shawnee Mission KS, 2016."},{"key":"26140_CR43","unstructured":"Caricato, M., et al., Gaussian 09: IOps Reference. 2009: Gaussian Wallingford, CT."},{"key":"26140_CR44","doi-asserted-by":"publisher","first-page":"136610","DOI":"10.1016\/j.molstruc.2023.136610","volume":"1295","author":"K Katariya","year":"2024","unstructured":"Katariya, K. et al. New symmetric\/unsymmetrical self-assembling salicylaldimine-chalcones: Synthesis, photophysical study and DFT approach. J. Mol. Struct. 1295, 136610 (2024).","journal-title":"J. Mol. Struct."},{"key":"26140_CR45","doi-asserted-by":"crossref","unstructured":"Soni, R., et al., Biphenyls embedded Schiff base-bis esters: self-assembling behaviour, impact of additional aromatic ring and ester linkage and their DFT investigations. Liq. Cryst. 1\u201315 (2024).","DOI":"10.1080\/02678292.2024.2350044"},{"issue":"10","key":"26140_CR46","doi-asserted-by":"publisher","first-page":"7950","DOI":"10.1039\/D4CP00266K","volume":"26","author":"V Butera","year":"2024","unstructured":"Butera, V. Density functional theory methods applied to homogeneous and heterogeneous catalysis: a short review and a practical user guide. Phys. Chem. Chem. Phys. 26(10), 7950\u20137970 (2024).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"26140_CR47","doi-asserted-by":"crossref","unstructured":"Politzer, P. & Murray, J. S. Molecular electrostatic potentials: significance and applications. Chemical reactivity in confined systems: theory, modelling and applications 113\u2013134 (2021).","DOI":"10.1002\/9781119683353.ch7"},{"issue":"2","key":"26140_CR48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41428-023-00843-z","volume":"56","author":"K Tanaka","year":"2024","unstructured":"Tanaka, K. New strategy for lowering the energy levels of one frontier molecular orbital in conjugated molecules and polymers based on Aza-substitution at the isolated HOMO or LUMO. Polym. J. 56(2), 61\u201370 (2024).","journal-title":"Polym. J."},{"issue":"1","key":"26140_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42234-018-0001-z","volume":"4","author":"P Sanjuan-Alberte","year":"2018","unstructured":"Sanjuan-Alberte, P. et al. Electrochemically stimulating developments in bioelectronic medicine. Bioelectron. Med. 4(1), 1 (2018).","journal-title":"Bioelectron. Med."},{"issue":"16","key":"26140_CR50","doi-asserted-by":"publisher","first-page":"9643","DOI":"10.1039\/C9RA10499B","volume":"10","author":"NH Ahmed","year":"2020","unstructured":"Ahmed, N. H. et al. New wide-stability four-ring azo\/ester\/Schiff base liquid crystals: Synthesis, mesomorphic, photophysical, and DFT approaches. RSC Adv. 10(16), 9643\u20139656 (2020).","journal-title":"RSC Adv."},{"issue":"10","key":"26140_CR51","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1002\/jps.24557","volume":"104","author":"YS Elnaggar","year":"2015","unstructured":"Elnaggar, Y. S. et al. Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer\u2019s disease: optimization, biological efficacy, and potential toxicity. J. Pharm. Sci. 104(10), 3544\u20133556 (2015).","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"26140_CR52","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.foodchem.2008.10.015","volume":"114","author":"PL Fal\u00e9","year":"2009","unstructured":"Fal\u00e9, P. L. et al. Rosmarinic acid, scutellarein 4\u2032-methyl ether 7-O-glucuronide and (16S)-coleon E are the main compounds responsible for the antiacetylcholinesterase and antioxidant activity in herbal tea of Plectranthus barbatus (\u201cfalso boldo\u201d). Food Chem. 114(3), 798\u2013805 (2009).","journal-title":"Food Chem."},{"key":"26140_CR53","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00109-012-0880-5","volume":"90","author":"JD Ho","year":"2012","unstructured":"Ho, J. D., Man, H. J. & Marsden, P. A. Nitric oxide signaling in hypoxia. J. Mol. Med. 90, 217\u2013231 (2012).","journal-title":"J. Mol. Med."},{"issue":"2","key":"26140_CR54","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1006\/bbrc.1994.1764","volume":"201","author":"L Marcocci","year":"1994","unstructured":"Marcocci, L. et al. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem. Biophys. Res. Commun. 201(2), 748\u2013755 (1994).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"26140_CR55","unstructured":"Sadique, J., et al., The bio-activity of certain medicinal plants on the stabilization of RBC membrane system (1989)."},{"issue":"2","key":"26140_CR56","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ab.2013.06.007","volume":"441","author":"W Lu","year":"2013","unstructured":"Lu, W. et al. Development of a new colorimetric assay for lipoxygenase activity. Anal. Biochem. 441(2), 162\u2013168 (2013).","journal-title":"Anal. Biochem."},{"key":"26140_CR57","doi-asserted-by":"crossref","unstructured":"Prayoga, D.K., et al., Phytochemical Analysis, Computational Study, and in vitro Assay of Etlingera elatior Inflorescence Extract Towards Inducible Nitric Oxide Synthase. J. Exp. Pharmacol 123\u2013141 (2025).","DOI":"10.2147\/JEP.S505658"},{"key":"26140_CR58","doi-asserted-by":"publisher","first-page":"106749","DOI":"10.1016\/j.bioorg.2023.106749","volume":"139","author":"PVR Kiran","year":"2023","unstructured":"Kiran, P. V. R. et al. Design and development of benzyl piperazine linked 5-phenyl-1, 2, 4-triazole-3-thione conjugates as potential agents to combat Alzheimer\u2019s disease. Bioorg. Chem. 139, 106749 (2023).","journal-title":"Bioorg. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26140-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26140-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26140-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:04:00Z","timestamp":1763723040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26140-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26140"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26140-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experimental design was approved by the committee applications for the institutional animal care and use committees (IACUC-SRTA city with approval number Tx-Rb-17\u20133-9-2025). The rabbit blood samples (animal facility of Center of Excellence for Drug Preclinical Studies (CE-DPS), Pharmaceutical and Fermentation Industry Development Center, City of Scientific Research & Technological Applications (SRTA-city)).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"41157"}}